A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia

ABSTRACT: Consolidation therapies for children with intermediate- or high-risk acute myeloid leukemia (AML) are urgently needed to achieve higher cure rates while limiting therapy-related toxicities. We determined if adoptive transfer of natural killer (NK) cells from haploidentical killer immunoglo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Rosa, Wu, Huiyun, Pounds, Stanley, Inaba, Hiroto, Ribeiro, Raul C., Cullins, David, Rooney, Barbara, Bell, Teresa, Lacayo, Norman J., Heym, Kenneth, Degar, Barbara, Schiff, Deborah, Janssen, William E., Triplett, Brandon, Pui, Ching-Hon, Leung, Wing, Rubnitz, Jeffrey E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425674/
https://www.ncbi.nlm.nih.gov/pubmed/30894213
http://dx.doi.org/10.1186/s40425-019-0564-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425674/
https://www.ncbi.nlm.nih.gov/pubmed/30894213
http://dx.doi.org/10.1186/s40425-019-0564-6

Ejemplares similares